Drug Shortage Report for ADENOSINE INJECTION

Last updated on 2018-02-01 History
Report ID 29048
Drug Identification Number 02267659
Brand name ADENOSINE INJECTION
Common or Proper name Adenosine Injection
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) ADENOSINE
Strength(s) 3MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 3mg/mL 2mL
ATC code C01EB
ATC description OTHER CARDIAC PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-11-10
Estimated end date 2018-01-05
Actual end date 2017-12-21
Shortage status Resolved
Updated date 2018-02-01
Company comments Product on backorder, code K051002 Adenosine 3mg/mL 2mL Prefilled Syringe available for substitution.
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2018-02-01 French Compare
v10 2018-02-01 English Compare
v9 2018-02-01 English Compare
v8 2018-02-01 English Compare
v7 2018-02-01 English Compare
v6 2018-02-01 English Compare
v5 2017-12-22 French Compare
v4 2017-12-22 English Compare
v3 2017-11-13 French Compare
v2 2017-11-13 French Compare
v1 2017-11-13 English Compare